Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events-Reference-Cited by-同舟云学术

Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events

Published:2015-02 Issue:2 Volume:26 Page:368-374
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Smith M.R.,Coleman R.E.,Klotz L.,Pittman K.,Milecki P.,Ng S.,Chi K.N.,Balakumaran A.,Wei R.,Wang H.,Braun A.,Fizazi K.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/26/2/368/5032790/mdu519.pdf

Reference21 articles.

1. New and emerging therapies for bone metastases in genitourinary cancers;Saylor;Eur Urol,2013

2. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients;Bubendorf;Hum Pathol,2000

3. Skeletal complications of malignancy;Coleman;Cancer,1997

4. Clinical features of metastatic bone disease and risk of skeletal morbidity;Coleman;Clin Cancer Res,2006

5. The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer;Weinfurt;Ann Oncol,2005

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are bone targeted agents still useful in times of immunotherapy? The SAKK 80/19 BTA pilot study;Bone Reports;2024-09

2. A Multidisciplinary Update on Treatment Modalities for Metastatic Spinal Tumors with a Surgical Emphasis: A Literature Review and Evaluation of the Role of Artificial Intelligence;Cancers;2024-08-08

3. The emerging role of osteoclasts in the treatment of bone metastases: rationale and recent clinical evidence;Frontiers in Oncology;2024-08-01

4. A multifaceted role of bisphosphonates from palliative care to anti-cancer therapy in solid tumors;Journal of Oncology Pharmacy Practice;2024-07-26

5. Correlation analyses of radiographic progression‐free survival with clinical and health‐related quality of life outcomes in metastatic castration‐resistant prostate cancer: Analysis of the phase 3 VISION trial;Cancer;2024-06-21